These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 26541602)

  • 1. Effects of rs3846662 Variants on HMGCR mRNA and Protein Levels and on Markers of Alzheimer's Disease Pathology.
    Leduc V; Théroux L; Dea D; Dufour R; Poirier J
    J Mol Neurosci; 2016 Jan; 58(1):109-19. PubMed ID: 26541602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of rs3846662 and HMGCR alternative splicing in statin efficacy and baseline lipid levels in familial hypercholesterolemia.
    Leduc V; Bourque L; Poirier J; Dufour R
    Pharmacogenet Genomics; 2016 Jan; 26(1):1-11. PubMed ID: 26466344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of HMGCR polymorphism with late-onset Alzheimer's disease in Han Chinese.
    Chang XL; Tan L; Tan MS; Wang HF; Tan CC; Zhang W; Zheng ZJ; Kong LL; Wang ZX; Jiang T; Yu JT; Tan L
    Oncotarget; 2016 Apr; 7(16):22746-51. PubMed ID: 27009838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of HMGCR genetic variation on neuroimaging biomarkers in healthy, mild cognitive impairment and Alzheimer's disease cohorts.
    Cao L; Wang HF; Tan L; Sun FR; Tan MS; Tan CC; Jiang T; Yu JT; Tan L;
    Oncotarget; 2016 Mar; 7(12):13319-27. PubMed ID: 26950278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association study of rs3846662 with Alzheimer's disease in a population-based cohort: the Cache County Study.
    Wright SM; Jensen SL; Cockriel KL; Davis B; Tschanz JT; Munger RG; Corcoran CD; Kauwe JSK
    Neurobiol Aging; 2019 Dec; 84():242.e1-242.e6. PubMed ID: 30975575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Common SNPs in HMGCR in micronesians and whites associated with LDL-cholesterol levels affect alternative splicing of exon13.
    Burkhardt R; Kenny EE; Lowe JK; Birkeland A; Josowitz R; Noel M; Salit J; Maller JB; Pe'er I; Daly MJ; Altshuler D; Stoffel M; Friedman JM; Breslow JL
    Arterioscler Thromb Vasc Biol; 2008 Nov; 28(11):2078-84. PubMed ID: 18802019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TAU haplotype and the Saitohin Q7R gene polymorphism do not influence CSF Tau in Alzheimer's disease and are not associated with frontotemporal dementia or Parkinson's disease.
    Johansson A; Zetterberg H; Håkansson A; Nissbrandt H; Blennow K
    Neurodegener Dis; 2005; 2(1):28-35. PubMed ID: 16909000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-106b inhibits tau phosphorylation at Tyr18 by targeting Fyn in a model of Alzheimer's disease.
    Liu W; Zhao J; Lu G
    Biochem Biophys Res Commun; 2016 Sep; 478(2):852-7. PubMed ID: 27520374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isoprenoids and tau pathology in sporadic Alzheimer's disease.
    Pelleieux S; Picard C; Lamarre-Théroux L; Dea D; Leduc V; Tsantrizos YS; Poirier J
    Neurobiol Aging; 2018 May; 65():132-139. PubMed ID: 29476987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein markers for Alzheimer disease in the frontal cortex and cerebellum.
    Verdile G; Gnjec A; Miklossy J; Fonte J; Veurink G; Bates K; Kakulas B; Mehta PD; Milward EA; Tan N; Lareu R; Lim D; Dharmarajan A; Martins RN
    Neurology; 2004 Oct; 63(8):1385-92. PubMed ID: 15505153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid beta increases ABCA1 and HMGCR protein expression, and cholesterol synthesis and accumulation in mice neurons and astrocytes.
    Azizidoost S; Babaahmadi-Rezaei H; Nazeri Z; Cheraghzadeh M; Kheirollah A
    Biochim Biophys Acta Mol Cell Biol Lipids; 2022 Jan; 1867(1):159069. PubMed ID: 34744007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternative splicing of 3-hydroxy-3-methylglutaryl coenzyme A reductase is associated with plasma low-density lipoprotein cholesterol response to simvastatin.
    Medina MW; Gao F; Ruan W; Rotter JI; Krauss RM
    Circulation; 2008 Jul; 118(4):355-62. PubMed ID: 18559695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic Polymorphisms in the
    Pierzchlińska A; Sławek J; Kwaśniak-Butowska M; Malinowski D; Komaniecka N; Mak M; Czerkawska A; Kukowka A; Białecka M
    Int J Mol Sci; 2024 Aug; 25(16):. PubMed ID: 39201649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptomics and mechanistic elucidation of Alzheimer's disease risk genes in the brain and in vitro models.
    Martiskainen H; Viswanathan J; Nykänen NP; Kurki M; Helisalmi S; Natunen T; Sarajärvi T; Kurkinen KM; Pursiheimo JP; Rauramaa T; Alafuzoff I; Jääskeläinen JE; Leinonen V; Soininen H; Haapasalo A; Huttunen HJ; Hiltunen M
    Neurobiol Aging; 2015 Feb; 36(2):1221.e15-28. PubMed ID: 25281018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HMGCR is a genetic modifier for risk, age of onset and MCI conversion to Alzheimer's disease in a three cohorts study.
    Leduc V; De Beaumont L; Théroux L; Dea D; Aisen P; Petersen RC; ; Dufour R; Poirier J
    Mol Psychiatry; 2015 Jul; 20(7):867-73. PubMed ID: 25023145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HNRNPA1 regulates HMGCR alternative splicing and modulates cellular cholesterol metabolism.
    Yu CY; Theusch E; Lo K; Mangravite LM; Naidoo D; Kutilova M; Medina MW
    Hum Mol Genet; 2014 Jan; 23(2):319-32. PubMed ID: 24001602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of the functional variant in the 3-hydroxy-3-methylglutaryl-coenzyme a reductase gene with low-density lipoprotein-cholesterol in Japanese.
    Hiura Y; Tabara Y; Kokubo Y; Okamura T; Goto Y; Nonogi H; Miki T; Tomoike H; Iwai N
    Circ J; 2010 Mar; 74(3):518-22. PubMed ID: 20145341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between apolipoprotein E and the amyloid deposits and dystrophic neurites of Alzheimer's disease.
    Dickson TC; Saunders HL; Vickers JC
    Neuropathol Appl Neurobiol; 1997 Dec; 23(6):483-91. PubMed ID: 9460714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tau load is associated with apolipoprotein E genotype and the amount of amyloid beta protein, Abeta40, in sporadic and familial Alzheimer's disease.
    Thaker U; McDonagh AM; Iwatsubo T; Lendon CL; Pickering-Brown SM; Mann DM
    Neuropathol Appl Neurobiol; 2003 Feb; 29(1):35-44. PubMed ID: 12581338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low amyloid (Abeta) plaque load and relative predominance of diffuse plaques distinguish argyrophilic grain disease from Alzheimer's disease.
    Tolnay M; Calhoun M; Pham HC; Egensperger R; Probst A
    Neuropathol Appl Neurobiol; 1999 Aug; 25(4):295-305. PubMed ID: 10476046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.